Brenda M. Gannon
Assistant Professor
University of Arkansas for Medical Sciences
faculty
Research Areas
Links
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Brenda M. Gannon's research investigates the pharmacological effects and abuse liability of various psychoactive substances, with a particular focus on their interactions with monoamine transporters. Her work has examined substituted amphetamines, cathinones, and arylcyclohexylamines, exploring their structure-activity relationships and their potential for abuse. Gannon also studies the self-administration of drugs, including oxycodone, in animal models, correlating responses with genetic predispositions. Her investigations extend to the role of the endocannabinoid system in alcohol dependence and the development of cannabinoids as therapeutic agents. She has published 48 papers, accumulating 902 citations, and holds an h-index of 16. Gannon collaborates with researchers at the University of Arkansas for Medical Sciences, including William E. Fantegrossi, with whom she shares nine publications, and Christopher O. Godwin and Heidi D. Hughes-Meredith, with whom she has two shared publications each.
Metrics
- h-index: 16
- Publications: 48
- Citations: 902
Selected Publications
- Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations (2025) DOI
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption (2025) DOI
- Respiratory Depressant Effects of Fentanyl in Combination With Synthetic Cannabinoid Receptor Agonists: A Potential Mechanism for “Narcan-Resistant” Overdose (2024) DOI
- The Development of Cannabinoids as Therapeutic Agents in the United States (2024) DOI
- Erratum to “Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety” [Drug Alcohol Depend. 250 (2023) 110917] (2024) DOI
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents (2024) DOI
- Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones (2023) DOI
- Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety (2023) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics